Concepedia
Statistics
Publications
7
Citations
172
H-Index
Active since
2009
Affiliations
Syngene International (India)(Current)
Bristol-Myers Squibb (India)
Bristol-Myers Squibb (Germany)
Biocon (India)
Chetan P. Kulkarni is an author at Syngene International (India) specializing in pharmacology, pharmacy, and drug disposition.
Publications per year
2009–2021
Effect of pretreatment with coenzyme Q10 on isoproterenol-induced cardiotoxicity and cardiac hypertrophy in rats
Arvindkumar E. Ghule, Chetan P. Kulkarni, Subhash L. Bodhankar et al. · Current Therapeutic Research · 2009 · 42 citations · Full text
Medicine, Pharmacology, Toxicology +16
A Simplified Protocol Employing Elacridar in Rodents: A Screening Model in Drug Discovery to Assess P-gp Mediated Efflux at the Blood Brain Barrier
Rajareddy Kallem, Chetan P. Kulkarni, Dakshay Patel et al. · Drug Metabolism Letters · 2012 · 31 citations
Pharmacy, Pharmacokinetics, Pharmacology +14
Rajareddy Kallem, Chetan P. Kulkarni, Dakshay Patel et al. · Drug Metabolism Letters · 2012 · 29 citations
Antidiabetic activity of Trigonella foenumgraecum L. seeds extract (IND01) in neonatal streptozotocin-induced (n-STZ) rats.
Chetan P. Kulkarni, Subhash L. Bodhankar, Arvindkumar E. Ghule et al. · Diabetologia Croatica · 2012 · 28 citations
Medicine, Endocrinology, Pharmacology +11
Characterization of SGLT1-mediated glucose transport in Caco-2 cell monolayers, and absence of its regulation by sugar or epinephrine
Chetan P. Kulkarni, Johan M. Thevelein, Walter Luyten · European Journal of Pharmacology · 2021 · 15 citations
Life Sciences, Biochemistry, Physiology +13
1–5 of 7